Alberto Casellas - 01 May 2026 Form 4 Insider Report for Synchrony Financial (SYF)

Reporting relationship: EVP, CEO--Health & Wellness
Issuer ticker: SYF
Reported as of: 01 May 2026
Net transaction value: -$443,531
SEC form: 4
Accepted by SEC: 05 May 2026, 16:20:50 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Danielle Do as attorney in fact

Key filing fact

Alberto Casellas filed Form 4 for Synchrony Financial (SYF) on 05 May 2026.

Key facts

This page summarizes Alberto Casellas's Form 4 filing for Synchrony Financial (SYF).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 May 2026, 16:20.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: -$443,531.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763554 Primary reporting owner

Casellas Alberto

Relationship: EVP, CEO--Health & Wellness
Address: 777 LONG RIDGE ROAD, C/O CORPORATE SECRETARY, STAMFORD
Signature: /s/ Danielle Do as attorney in fact
Signature date: 05 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYF transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,794
Change %: +12%
Price: $34.30^*
Shares after: 56,125
Date: 01 May 2026
Ownership: Direct
Footnotes: F1

SYF transaction

Common Stock

Sale

Transaction value: $443,531
Shares: -5,794
Change %: -10%
Price: $76.55
Shares after: 50,331
Date: 01 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SYF transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -5,794
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,794
Exercise price: $34.30
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on October 27, 2025.

Footnote F2

The reporting person was awarded 11,588 employee stock options on April 1, 2017, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.

SEC remarks

EVP, CEO--Health & Wellness